161 related articles for article (PubMed ID: 20459741)
1. Cyclin K and cyclin D1b are oncogenic in myeloma cells.
Marsaud V; Tchakarska G; Andrieux G; Liu JM; Dembele D; Jost B; Wdzieczak-Bakala J; Renoir JM; Sola B
Mol Cancer; 2010 May; 9():103. PubMed ID: 20459741
[TBL] [Abstract][Full Text] [Related]
2. Relevance of cyclin D1b expression and CCND1 polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphoma.
Krieger S; Gauduchon J; Roussel M; Troussard X; Sola B
BMC Cancer; 2006 Oct; 6():238. PubMed ID: 17022831
[TBL] [Abstract][Full Text] [Related]
3. Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene.
Olshavsky NA; Comstock CE; Schiewer MJ; Augello MA; Hyslop T; Sette C; Zhang J; Parysek LM; Knudsen KE
Cancer Res; 2010 May; 70(10):3975-84. PubMed ID: 20460515
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation.
Solomon DA; Wang Y; Fox SR; Lambeck TC; Giesting S; Lan Z; Senderowicz AM; Conti CJ; Knudsen ES
J Biol Chem; 2003 Aug; 278(32):30339-47. PubMed ID: 12746453
[TBL] [Abstract][Full Text] [Related]
5. Alternative splicing of the cyclin D1 proto-oncogene is regulated by the RNA-binding protein Sam68.
Paronetto MP; Cappellari M; Busà R; Pedrotti S; Vitali R; Comstock C; Hyslop T; Knudsen KE; Sette C
Cancer Res; 2010 Jan; 70(1):229-39. PubMed ID: 20028857
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1b overexpression inhibits cell proliferation and induces cell apoptosis in cervical cancer cells in vitro and in vivo.
Wang N; Wei H; Yin D; Lu Y; Zhang Y; Jiang D; Jiang Y; Zhang S
Int J Clin Exp Pathol; 2014; 7(7):4016-23. PubMed ID: 25120779
[TBL] [Abstract][Full Text] [Related]
7. Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.
Li R; An SJ; Chen ZH; Zhang GC; Zhu JQ; Nie Q; Xie Z; Guo AL; Mok TS; Wu YL
Hum Pathol; 2008 Dec; 39(12):1792-801. PubMed ID: 18715616
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1b in human breast carcinoma and coexpression with cyclin D1a is associated with poor outcome.
Abramson VG; Troxel AB; Feldman M; Mies C; Wang Y; Sherman L; McNally S; Diehl A; Demichele A
Anticancer Res; 2010 Apr; 30(4):1279-85. PubMed ID: 20530440
[TBL] [Abstract][Full Text] [Related]
9. Enhanced skin carcinogenesis and lack of thymus hyperplasia in transgenic mice expressing human cyclin D1b (CCND1b).
Rojas P; Benavides F; Blando J; Perez C; Cardenas K; Richie E; Knudsen ES; Johnson DG; Senderowicz AM; Rodriguez-Puebla ML; Conti CJ
Mol Carcinog; 2009 Jun; 48(6):508-16. PubMed ID: 18942117
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1b variant promotes cell invasiveness independent of binding to CDK4 in human bladder cancer cells.
Kim CJ; Nishi K; Isono T; Okuyama Y; Tambe Y; Okada Y; Inoue H
Mol Carcinog; 2009 Oct; 48(10):953-64. PubMed ID: 19415719
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1b splice variant promotes αvβ3-mediated adhesion and invasive migration of breast cancer cells.
Wu FH; Luo LQ; Liu Y; Zhan QX; Luo C; Luo J; Zhang GM; Feng ZH
Cancer Lett; 2014 Dec; 355(1):159-67. PubMed ID: 25193465
[TBL] [Abstract][Full Text] [Related]
12. Anti-oncogenic activities of cyclin D1b siRNA on human bladder cancer cells via induction of apoptosis and suppression of cancer cell stemness and invasiveness.
Kim CJ; Terado T; Tambe Y; Mukaisho KI; Sugihara H; Kawauchi A; Inoue H
Int J Oncol; 2018 Jan; 52(1):231-240. PubMed ID: 29115414
[TBL] [Abstract][Full Text] [Related]
13. An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene.
Lu F; Gladden AB; Diehl JA
Cancer Res; 2003 Nov; 63(21):7056-61. PubMed ID: 14612495
[TBL] [Abstract][Full Text] [Related]
14. Alteration of cyclin D1 transcript elongation by a mutated transcription factor up-regulates the oncogenic D1b splice isoform in cancer.
Sanchez G; Bittencourt D; Laud K; Barbier J; Delattre O; Auboeuf D; Dutertre M
Proc Natl Acad Sci U S A; 2008 Apr; 105(16):6004-9. PubMed ID: 18413612
[TBL] [Abstract][Full Text] [Related]
15. Identification of the cyclin D1b mRNA variant in mouse.
Wu J; Wu SH; Bollig A; Thakur A; Liao DJ
Mol Biol Rep; 2009 May; 36(5):953-7. PubMed ID: 18446443
[TBL] [Abstract][Full Text] [Related]
16. Female-specific rectal carcinogenesis in cyclin D1b transgenic mice.
Kim CJ; Tambe Y; Mukaisho K; Sugihara H; Isono T; Sonoda H; Shimizu T; Kondoh G; Inoue H
Carcinogenesis; 2014 Jan; 35(1):227-36. PubMed ID: 23975835
[TBL] [Abstract][Full Text] [Related]
17. Association between CCND1 G/A870 polymorphism, allele-specific amplification, cyclin D1 expression, and survival in esophageal and lung carcinoma.
Gupta VK; Feber A; Xi L; Pennathur A; Wu M; Luketich JD; Godfrey TE
Clin Cancer Res; 2008 Dec; 14(23):7804-12. PubMed ID: 19047108
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation.
Burd CJ; Petre CE; Morey LM; Wang Y; Revelo MP; Haiman CA; Lu S; Fenoglio-Preiser CM; Li J; Knudsen ES; Wong J; Knudsen KE
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2190-5. PubMed ID: 16461912
[TBL] [Abstract][Full Text] [Related]
19. PACSIN 2 represses cellular migration through direct association with cyclin D1 but not its alternate splice form cyclin D1b.
Meng H; Tian L; Zhou J; Li Z; Jiao X; Li WW; Plomann M; Xu Z; Lisanti MP; Wang C; Pestell RG
Cell Cycle; 2011 Jan; 10(1):73-81. PubMed ID: 21200149
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome.
Millar EK; Dean JL; McNeil CM; O'Toole SA; Henshall SM; Tran T; Lin J; Quong A; Comstock CE; Witkiewicz A; Musgrove EA; Rui H; Lemarchand L; Setiawan VW; Haiman CA; Knudsen KE; Sutherland RL; Knudsen ES
Oncogene; 2009 Apr; 28(15):1812-20. PubMed ID: 19287456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
